Hillenbrand Inc (HI) Stock News

HII's Newport News Shipbuilding division has been awarded approximately $76.6 billion in contract modifications from the U.S. Navy for construction of Block VI Virginia-class and Build II Columbia-class submarines. The contracts include five additional Columbia-class submarines, nine additional Virginia-class submarines, and shipyard infrastructure funding, shared with General Dynamics Electric Boat.

Value Line, Inc. reported fiscal year 2026 net income of $21.63 million ($2.30 per share), up 4.6% from the prior year. The company declared a quarterly dividend of $0.35 per share, marking the 12th consecutive year of increases, with an annualized rate of $1.40 per share. Investment gains nearly doubled to $6.43 million, while liquid assets increased 11.7% to $86.47 million and shareholders' equity grew 8.2% to $107.89 million.

HII hosted Australian Minister for Defence Industry Pat Conroy at its Newport News Shipbuilding Charleston Operations facility to discuss the AUKUS trilateral partnership. The visit highlighted HII's distributed shipbuilding initiative and its role in supporting Australia's nuclear-powered submarine capability. The Charleston facility has increased production by over 50% under HII's ownership, and the company has qualified 13 Australian suppliers through its Australian Submarine Supplier Qualification (AUSSQ) Program.

Rosen Law Firm has filed a class action lawsuit on behalf of Microvast Holdings investors who purchased securities between April 1, 2025 and March 16, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding margin targets, inventory management issues, delays in commercial vehicle rollouts, and the completion timeline of the Huzhou Phase 3.2 expansion. Investors must move the court by September 21, 2026 to serve as lead plaintiff.

Peter Kendall has completed his mandate as Interim Chief Executive Officer of ARCpoint Inc. after 45 days, delivering his assessment and recommendations to the Board. His RSU grant has been pro-rated from 4 million to 2 million shares. The Board is now considering his recommendations and will seek to appoint a new CEO. Kendall will continue as an advisory consultant.

A securities class action lawsuit has been filed against Zoetis Inc. for allegedly making false and misleading statements about its Companion Animal products during January 2025 to May 2026. The lawsuit claims the company failed to disclose weakening veterinarian adoption of its Librela pain treatment following FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining sales in dermatology products Apoquel and Cytopoint. Investors who purchased securities during this period may be eligible for compensation.

Rosen Law Firm is soliciting lead plaintiffs for securities class action lawsuits against Badger Meter, Inc., First Solar, Inc., and Gildan Activewear Inc. The firm alleges that Badger Meter made false statements about financial results by pulling forward customer orders to conceal weakening demand. Investors with losses exceeding $100,000 are encouraged to join before the August 3, 2026 deadline.

J & J Snack Foods Corp. (JJSF) announced it will release financial results for fiscal Q3 ended June 27, 2026, on August 5, 2026, before market open. The company will host a conference call and webcast at 10:00 a.m. ET to discuss results. Investors can pre-register for the call via the company's investor relations website.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against PicS N.V., alleging the company made false and misleading statements in its January 2026 IPO offering documents. The lawsuit claims PicS failed to disclose deficient credit evaluation procedures, material reclassifications of credit exposures, undisclosed high Stage 3 formation rates, overstated credit models, and deteriorating customer credit quality. The lead plaintiff deadline is August 4, 2026.

Rosen Law Firm is reminding investors who purchased Futu Holdings Limited securities between May 24, 2023 and May 27, 2026 of an August 25, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Futu made materially false statements and failed to disclose non-compliance with China Securities Regulatory Commission requirements, including conducting securities and futures business without proper licenses, which resulted in overstated financial results.

Gilead Sciences is expanding beyond its core HIV business with four potential drug launches in 2026, including treatments for hepatitis delta virus, multiple myeloma, and breast cancer. Despite strong financials (Q1 revenue up 4% YoY, EPS up 54.8%), the stock has only risen 9% this year. The company's strategic acquisitions and diversified pipeline, combined with no major patent cliffs until 2036 and an attractive 2.39% dividend yield, suggest investors are undervaluing the company's growth potential.

Rosen Law Firm is encouraging investors who purchased securities of First Solar, Veritone, and Alibaba during specified periods to join class action lawsuits. First Solar faces allegations of overstating its capacity to manage U.S. tariff impacts and understating negative effects on 2026 fiscal year performance. The lead plaintiff deadline for First Solar is August 24, 2026.

Rosen Law Firm is notifying Roblox Corporation investors who purchased stock between October 30, 2025 and April 30, 2026 of an August 7, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Roblox provided misleading statements about organic growth potential, concealing material facts about significant slowdowns in growth rates due to age verification rollout impacts on user engagement and app store ratings.

Rosen Law Firm has filed a class action lawsuit on behalf of Genius Group Limited (GNS) investors for the period between April 12, 2022 and May 30, 2025. The lawsuit alleges that Citadel Securities LLC and Virtu Americas LLC engaged in illegal 'spoofing' practices—submitting and canceling orders without intent to execute them—to manipulate Genius stock prices and mislead market participants about supply, demand, and volatility. The defendants allegedly profited while increasing transaction costs for investors through inflated bid-ask spreads. The deadline to serve as lead plaintiff is August 28, 2026.

A securities class action lawsuit has been filed against Phreesia, Inc. for allegedly making false and misleading statements about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. Investors who purchased stock between May 8, 2025 and March 30, 2026 and suffered losses exceeding $100,000 are encouraged to join the class action before the July 13, 2026 lead plaintiff deadline.

A class action lawsuit has been filed against Graphic Packaging Holding Company for allegedly making false and misleading statements regarding inventory management issues, reduced demand, increased costs, and overstating business strength. The lawsuit covers securities purchased between February 4, 2025 and February 2, 2026. Investors have until July 6, 2026 to apply as lead plaintiff.

Rosen Law Firm announces securities class action lawsuits against AeroVironment, Futu Holdings Limited, and TruBridge, Inc. AeroVironment is accused of making false statements about competition risks related to U.S. Space Force contracts. Investors with losses exceeding $100,000 are encouraged to join the class actions before the July 27, 2026 lead plaintiff deadline.

HIVE Digital Technologies director Dave Perrill sold 175,000 common shares for approximately $821,000 on June 19, 2026, eliminating his direct equity holdings in the company. While Perrill retains over 600,000 RSUs, the timing of this sale following a 109% one-year stock surge raises concerns for investors. The stock has since declined 15% from the sale price, signaling potential weakness ahead.

Phinia's VP and Controller Samantha Pombier sold 2,227 shares (25.1% of her direct holdings) for approximately $183,000. Despite the insider sale, analysts view the company favorably due to its dual-channel business model serving both OEMs and the aftermarket, strong Q1 2026 results with 10% revenue growth, and strategic expansion into alternative fuels. The stock trades at a forward P/E of ~11x, presenting a reasonable entry point for investors.

HII and the U.S. Navy opened a new 80,000 square-foot Carrier Refueling Overhaul Workcenter (CROW) at Newport News Shipbuilding to improve working conditions for sailors and shipbuilders during nuclear aircraft carrier maintenance. The facility provides office spaces and quality-of-service areas, supporting the Navy's 'Sailors First' vision and enhancing operational readiness.

Vaxart is urging shareholders to vote for all six of its director nominees on the WHITE proxy card ahead of its July 16, 2026 Annual Meeting. The company highlights strategic progress on its oral vaccine pipeline, including Phase 2b COVID-19 trials and partnerships with Dynavax, while defending its board against dissident nominees it claims lack relevant biotech expertise. Vaxart has made multiple settlement offers to resolve the proxy contest.

LA21-CDC received grant support from Truist Foundation to expand its Small Business Sustainability Initiative, which provides Philadelphia entrepreneurs with coaching, business systems training, capital readiness support, and AI-powered business tools to strengthen operations and build long-term sustainability.

HII's Mission Technologies division has been awarded a $418 million, five-year IDIQ contract by Naval Sea Systems Command to repair, maintain, and provide technical support for shipboard elevators and cargo handling equipment on U.S. Navy aircraft carriers and amphibious ships. The contract leverages over 40 years of elevator support experience and includes sailor training and rapid-response maintenance teams.

Rosen Law Firm is notifying investors in AeroVironment, Commvault Systems, and Calix who suffered losses exceeding $100K about securities class action lawsuits. The lawsuits allege that these companies made false or misleading statements regarding their business prospects and financial performance during specified class periods. Investors have until July 27, 2026 to serve as lead plaintiffs.

First United Corporation (NASDAQ:FUNC) announced that its Board of Directors declared a cash dividend of $0.26 per share, payable on August 3, 2026, to shareholders of record as of July 20, 2026.

– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets – Company publishes Q1 2026 financial results with revenue in line with prior guidance & substantial year-on-year gross margin percentage improvements DUBLIN, June 16, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB ), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received additional purchase orders for over 2 million units of its flagship rapid HIV test, TrinScreen™ HIV. These orders are scheduled for fulfillment in Q3 2026 and are expected to make a meaningful contribution to the Company's 2026 revenue and profitability objectives. These orders provide further evidence of renewed, broad-based demand for rapid HIV diagnostics across global health markets, following disruptions in 2025 due to changes affecting international aid funding structures. TrinScreen™ HIV is a WHO prequalified point of care diagnostic test designed for use in high-volume community screening programs in countries with high HIV prevalence, offering reliable results and ease of use in diverse clinical settings. These orders will be manufactured under the new offshored and outsourced manufacturing process, a key deliverable in the Company's Comprehensive Transformation Plan, which provides for efficient and cost-effective scalability. John Gillard, CEO of Trinity Biotech, commented: " Recent outbreaks of Ebola and Hantavirus serve as an important reminder of the ongoing public health risks posed by infectious diseases. Against this backdrop, these additional orders for TrinScreen HIV represent a further welcome indication of renewed focus on HIV disease management. " In addition, the Company continues to execute the commercial

Delivered strong Q1 2026 comparable store sales growth 1 of 22.6% and total revenue growth of 37.0% Achieved a four-year high gross margin 1 of 67.4 %, an increase of 530 bps Expanded adjusted EBITDA margin 1 to 36.8 %, underscoring our luxury-inspired business model Continued successful expansion with new stores outperforming expectations Raised adjusted EBITDA margin guidance for Fiscal 2026 to 38.25%–39.50 % MONTRÉAL , June 16, 2026 /CNW/ - Groupe Dynamite Inc. ("Groupe Dynamite" or the "Company") (TSX: GRGD ) today reported its financial results for the fiscal year 2026's first quarter ended May 2, 2026. "Our first quarter results demonstrate the strength of our operating model and our ability to deliver profitable growth. Comparable store sales increased 22.6%, gross margin reached a four-year high, and adjusted EBITDA margin expanded to 36.8% of revenue, positioning ourselves alongside the world's most profitable fashion houses. We continue to strive to remain a highly productive specialty retailer with strong brands, exceptional unit economics, disciplined inventory management, attractive returns on capital, and a growth engine we have built over decades that continues to scale profitably," said Andrew Lutfy, Chief Executive Officer and Chair of the Board. "Q1 was a strong start to fiscal 2026. Across both GARAGE and DYNAMITE, customers responded positively to our assortments, marketing campaigns and the consistency of the experience we deliver across channels. Our real estate strategy continues to be a significant driver of growth, customer acquisition and profitability. By opening new locations in premium centers, optimizing our fleet and delivering a compelling in-store experience, we continue to drive significant productivity improvements across our store network. Most importantly, we continue to see strong customer engagement across both brands, reflected

MOUNT GILEAD, N.C. , June 15, 2026 /PRNewswire/ -- McRae Industries, Inc. (Pink Sheets: MCRAA and MCRAB) reported consolidated net revenues for the third quarter of fiscal 2026 of $27,418,000 as compared to $30,870,000 for the third quarter of fiscal 2025. Net earnings for the third quarter of fiscal 2026 amounted to $858,000, or $0.38 per diluted Class A common share, as compared to $3,160,000, or $1.40 per diluted Class A common share, for the third quarter of fiscal 2025. Consolidated net revenues for the first nine months of fiscal 2026 totaled $86,569,000 as compared to $87,120,000 for the first nine months of fiscal 2025. Net earnings for the first nine months of fiscal 2026 amounted to $3,262,000, or $1.45 per diluted Class A common share, as compared to net earnings of $6,059,000, or $2.68 per diluted Class A common share, for the first nine months of fiscal 2025. THIRD QUARTER FISCAL 2026 COMPARED TO THIRD QUARTER FISCAL 2025 Consolidated net revenues totaled $27.4 million for the third quarter of fiscal 2026 as compared to $30.9 million for the third quarter of fiscal 2025. Sales related to our western/lifestyle boot products for the third quarter of fiscal 2026 totaled $19.7 million as compared to $20.2 million for the third quarter of fiscal 2025. This decrease in net revenues was mainly driven by a decrease in our Laredo brand. Revenues from our work boot products decreased from $8.7 million for the third quarter of fiscal 2025 to $7.9 million for the third quarter of fiscal 2026. This was primarily a result of decreased orders on military boots. Additionally, third quarter revenues for fiscal 2025 included $2.0 million in land sales through our affiliate American Mortgage Investment Company (AMIC). Consolidated gross profit for the third quarter of fiscal 2026 amounted to approximately $6.9 million as compared to $9.8 million for the third quarter of fis

A class action lawsuit has been filed against Graphic Packaging Holding Company for allegedly making false and misleading statements regarding inventory management issues, reduced demand, increased costs, and unreliable financial guidance for FY 2025. Investors who purchased securities between February 4, 2025 and February 2, 2026 have until July 6, 2026 to apply as lead plaintiff.

A federal securities class action has been filed against PicS N.V. (NASDAQ: PICS) alleging that the company and its executives made false and misleading statements in connection with its January 30, 2026 IPO. The lawsuit claims PicS concealed deficiencies in credit evaluation procedures discovered in December 2025, including the reclassification of R$590 million in exposures to its highest risk category and a Stage 3 formation rate exceeding 7%. Following the disclosure of these issues on March 18, 2026, PICS stock fell 22.5% from its $19.00 IPO price to $12.27. The deadline to seek lead plaintiff appointment is August 4, 2026.